We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Cardinal Health on Friday agreed to acquire Integrated Oncology Network, an independent community oncology network, for $1.12 billion in cash.
DUBLIN, Ohio, Aug. 21, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its plans to open a new distribution center in Walton Hills, Ohio, supporting its U.S. Medical Products and ...
Cardinal Health's Walton Hills investment is part of a strategy to expand its U.S. medical products and distribution footprint and install new technology to better serve healthcare customers and ...
Cardinal Health Inc.’s stock rose 5% Wednesday, after the drug distributor and medical products maker beat estimates for its fiscal fourth quarter and raised its guidance. Dublin, Ohio-based ...
Cardinal Health (CAH) closed the latest trading day at $113.28, indicating a +0.1% change from the previous session's end. The stock fell short of the S&P 500, which registered a gain of 0.13% for ...
Cardinal Health stock remains a buy due to strong ... driven by pharmaceutical and medical products. DCF analysis supports a $128 price target, 17% upside, with Wall Street's average at $116 ...
The transaction, subject to regulatory approval, is expected to close later this year, a Cardinal spokesperson said.
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
View Cardinal Health, Inc. (CAH) current and estimated P/E ratio data provided by Seeking Alpha.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...